Serotonin as a biomarker of toxin-induced Parkinsonism.
Anna Marie BuchananSergio MenaIman ChoukariAditya VasaJesseca N CrawfordJim FadelNick MaxwellLawrence ReaganAllie CruikshankJanet BestH Fred NijhoutMichael ReedParastoo HashemiPublished in: Molecular medicine (Cambridge, Mass.) (2024)
These results validate key prior hypotheses about the roles of serotonin during PD and open an avenue to study to potentially improve therapeutics for levodopa-induced dyskinesia and depression.